Sale!

RFXANK Gene Bare Lymphocyte Syndrome Type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The RFXANK Gene Bare Lymphocyte Syndrome Type 2 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the RFXANK gene, which are associated with Bare Lymphocyte Syndrome Type 2 (BLS2). This condition is a rare immunodeficiency disorder that affects the body’s ability to effectively respond to infections. The test plays a critical role in the early detection and management of the syndrome, facilitating personalized treatment plans to enhance patient outcomes.

Priced at 4400 AED, the test involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab, which is then analyzed in the state-of-the-art facilities of DNA Labs UAE. The laboratory utilizes advanced genetic sequencing technologies to accurately identify any mutations in the RFXANK gene, ensuring reliable results for patients and healthcare providers. By opting for this genetic test, individuals suspected of having Bare Lymphocyte Syndrome Type 2 can gain valuable insights into their condition, enabling timely and effective medical interventions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

RFXANK Gene Bare Lymphocyte Syndrome Type 2 Genetic Test

Cost: AED 4400.0

Introduction

The RFXANK gene is associated with a rare genetic disorder called Bare Lymphocyte Syndrome, type 2 (BLS2). BLS2 is an autosomal recessive disorder that affects the immune system, specifically the major histocompatibility complex (MHC) class II pathway. The MHC class II pathway is responsible for presenting antigens to T-cells, which play a crucial role in the immune response.

Test Components

  • Price: AED 4400.0
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Osteology Dermatology Immunology Disorders
  • Doctor: Dermatologist
  • Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for RFXANK Gene Bare lymphocyte syndrome, type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RFXANK Gene Bare lymphocyte syndrome, type 2 NGS Genetic DNA Test gene RFXANK.

Test Details

NGS (Next-Generation Sequencing) genetic testing can be used to identify mutations in the RFXANK gene. This type of testing allows for the simultaneous analysis of multiple genes, providing a comprehensive assessment of the genetic variations associated with BLS2. NGS genetic testing involves the sequencing of DNA fragments using high-throughput sequencing technologies. The obtained sequencing data is then analyzed to identify any genetic variations or mutations in the RFXANK gene that may be causing BLS2.

Genetic testing for BLS2 can help in confirming a diagnosis, providing information about the specific genetic mutation, and guiding treatment decisions. It can also be used for carrier testing in families with a history of BLS2. It is important to consult with a healthcare professional or a genetic counselor to understand the benefits, limitations, and implications of genetic testing for BLS2 before undergoing the test.

Test Name RFXANK Gene Bare lymphocyte syndrome type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for RFXANK Gene Bare lymphocyte syndrome, type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RFXANK Gene Bare lymphocyte syndrome, type 2 NGS Genetic DNA Test gene RFXANK
Test Details

The RFXANK gene is associated with a rare genetic disorder called Bare Lymphocyte Syndrome, type 2 (BLS2). BLS2 is an autosomal recessive disorder that affects the immune system, specifically the major histocompatibility complex (MHC) class II pathway.

The MHC class II pathway is responsible for presenting antigens to T-cells, which play a crucial role in the immune response. In BLS2, mutations in the RFXANK gene disrupt the normal functioning of the MHC class II pathway, leading to impaired immune responses.

NGS (Next-Generation Sequencing) genetic testing can be used to identify mutations in the RFXANK gene. This type of testing allows for the simultaneous analysis of multiple genes, providing a comprehensive assessment of the genetic variations associated with BLS2.

NGS genetic testing involves the sequencing of DNA fragments using high-throughput sequencing technologies. The obtained sequencing data is then analyzed to identify any genetic variations or mutations in the RFXANK gene that may be causing BLS2.

Genetic testing for BLS2 can help in confirming a diagnosis, providing information about the specific genetic mutation, and guiding treatment decisions. It can also be used for carrier testing in families with a history of BLS2.

It is important to consult with a healthcare professional or a genetic counselor to understand the benefits, limitations, and implications of genetic testing for BLS2 before undergoing the test.